7. J Exp Clin Cancer Res. 2018 Apr 10;37(1):79. doi: 10.1186/s13046-018-0733-3.Iron-dependent cell death as executioner of cancer stem cells.Zhao B(1)(2), Li X(1)(2), Wang Y(1)(2), Shang P(3)(4).Author information: (1)School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi,710072, China.(2)Key Laboratory for Space Bioscience and Biotechnology, Institute of SpecialEnvironment Biophysics, School of Life Science, Northwestern PolytechnicalUniversity, Xi'an, Shaanxi, 710072, China.(3)Research & Development Institute in Shenzhen, Northwestern PolytechnicalUniversity, Shenzhen, 518057, China. shangpeng@nwpu.edu.cn.(4)Key Laboratory for Space Bioscience and Biotechnology, Institute of SpecialEnvironment Biophysics, School of Life Science, Northwestern PolytechnicalUniversity, Xi'an, Shaanxi, 710072, China. shangpeng@nwpu.edu.cn.This commentary highlights the findings by Mai, et al. that ironomycin,derivatives of salinomycin, exhibited more potent and selective therapeuticactivity against breast cancer stem cells by accumulating and sequestering ironin lysosome, followed by an iron-mediated lysosomal production of reactive oxygenspecies and an iron-dependent cell death. These unprecedented findings identifiediron homeostasis and iron-mediated processes as potentially druggable in thecontext of cancer stem cells.DOI: 10.1186/s13046-018-0733-3 PMCID: PMC5894200PMID: 29636068 